Hostname: page-component-8448b6f56d-c4f8m Total loading time: 0 Render date: 2024-04-19T11:44:41.017Z Has data issue: false hasContentIssue false

Are people living in nursing homes receiving antidepressants in adequate doses?

Published online by Cambridge University Press:  11 December 2018

Robert Butler
Affiliation:
MHSOA, Waitemata District Health Board, Takapuna, Auckland, New Zealand
Raghavakurup Radhakrishnan*
Affiliation:
MHSOA, Waitemata District Health Board, Takapuna, Auckland, New Zealand University of Auckland, Auckland, New Zealand
*
Correspondence should be addressed to: Raghavakurup Radhakrishnan, MHSOA, Waitemata district health Board, Takapuna, Auckland; University of Auckland, New Zealand. Emails: Raghavakurup.Radhakrishnan@wiatematadhb.govt.nz; drradhakrishan@hotmail.com
Rights & Permissions [Opens in a new window]

Abstract

Type
Letter to the Editor
Copyright
© International Psychogeriatric Association 2018 

Studies have found that depression is common among nursing home residents. A systematic review estimated the median prevalence of major depressive disorder was 10%, while the median prevalence of depressive symptoms was 29% (Seitz et al., Reference Seitz, Purandare and Conn2010).

Antidepressants have been shown to be effective for older care home residents (Mottram et al., Reference Mottram, Wilson and Strobl2006). The rate of prescribing in care homes showed a steady increase from 1990s to this decade. In Leicestershire, UK, 11% of nursing home residents were receiving antidepressants in 1990, and the rate rose to 19% by 1997 (Arthur et al., Reference Arthur, Mathews, Jagger and Lindesay2002). Borson et al. (Reference Borson, Scanlan, Doane and Gray2002) reported that in nursing facilities in the US 59% of the elderly on antidepressants received SSRIs.

Studies have shown that prescribing is often in inadequate doses (Snowdon et al., Reference Snowdon, Burgess, Vaughan and Miller1996). A review of the literature revealed limited information on adequacy of dose of antidepressants in the elderly. Our study investigates how widely antidepressants are prescribed in care homes and whether they are prescribed at adequate doses.

The study population consisted of all care home residents in the county of Suffolk, UK. All nursing homes in Suffolk were identified and included in the study. We wrote to all nursing home managers asking if they could provide medication sheets of residents. Anonymity of patients was maintained. Use of adequate dose in this group was assumed as 50% of recommended adult dose taken from various consensus guidelines.

Data was gathered from care home residents of all 44 care homes. In all 618/1450 (43%) of residents from 39 care homes out of 40 were prescribed an antidepressant. Also, 67 (4.6%) residents were on two antidepressants. Prescribing rates varied between 0-76% across care homes. Of these, 68% were “adequate dose.” Fifteen different antidepressants from different classes, namely SSRIs tricyclic antidepressants, typical antipsychotic, NaSSA, and SNRIs were used in these patients. SSRI was the most common antidepressant prescribed (23.7%). The three most common antidepressants were Citalopram, Mirtazapine, and Amitriptyline with a mean dose of 18.6mg, 28.4mg, and 24mg, respectively. There was a significantly high SSRI prescribing rate (Chi-square 235.69 p < .00001). SSRIs were more likely to be prescribed in adequate dose than other groups (Chi square 15.86 p < .001).

In summary, the study found that SSRIs were more likely to be prescribed at “adequate doses” but did not examine the reason for antidepressants prescription. There was an overall high prescription rate of antidepressants (43%). The findings are consistent with other studies (Arthur et al., Reference Arthur, Mathews, Jagger and Lindesay2002, Borson et al., Reference Borson, Scanlan, Doane and Gray2002; Snowdon et al., Reference Snowdon, Burgess, Vaughan and Miller1996) showing increased prescribing of antidepressants in care homes. There was a wide variability in prescribing rates between facilities.

Acknowledgments

The authors wish to thank all staff members at the care homes for their collaboration. We are grateful to Claire, research assistant, for help on collection and collation of data.

References

Arthur, A., Mathews, R., Jagger, C. and Lindesay, J. (2002). Factors associated with antidepressant treatment in residential care: changes between 1990 and 1997. International Journal of Geriatric Psychiatry, 17, 5460. doi: 10.1002/gps.512.CrossRefGoogle ScholarPubMed
Borson, S., Scanlan, J. M., Doane, K. and Gray, S. (2002). Antidepressant prescribing in nursing homes: is there a place for tricyclics? International Journal of Geriatric Psychiatry, 17, 11401145. doi: 10.1002/gps.766.CrossRefGoogle Scholar
Mottram, P. G., Wilson, K. and Strobl, J. J. (2006). Antidepressants for depressed elderly. Cochrane Database Systematic Review, Art. CD003491. doi: 10.1002/14651858.CD003491.pub2.CrossRefGoogle ScholarPubMed
Seitz, D., Purandare, N. and Conn, D. (2010). Prevalence of psychiatric disorders among older adults in long-term care homes: a systematic review. International Journal of Geriatric Psychiatry, 22, 10251039. doi: 10.1017/S1041610210000608.Google ScholarPubMed
Snowdon, J., Burgess, E., Vaughan, R. and Miller, R. (1996). Use of antidepressants, and prevalence of depression and cognitive impairment in Sydney nursing homes. International Journal of Geriatric Psychiatry, 11, 599606. doi: 10.1002/(SICI)1099-1166(199607)11:7<599::AID-GPS355>3.0.CO;2-F.3.0.CO;2-F>CrossRefGoogle Scholar